Correlation Between Gracell Biotechnologies and Replimune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gracell Biotechnologies and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gracell Biotechnologies and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gracell Biotechnologies and Replimune Group, you can compare the effects of market volatilities on Gracell Biotechnologies and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gracell Biotechnologies with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gracell Biotechnologies and Replimune.

Diversification Opportunities for Gracell Biotechnologies and Replimune

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Gracell and Replimune is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Gracell Biotechnologies and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Gracell Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gracell Biotechnologies are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Gracell Biotechnologies i.e., Gracell Biotechnologies and Replimune go up and down completely randomly.

Pair Corralation between Gracell Biotechnologies and Replimune

If you would invest  1,017  in Replimune Group on August 30, 2024 and sell it today you would earn a total of  388.00  from holding Replimune Group or generate 38.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy1.56%
ValuesDaily Returns

Gracell Biotechnologies  vs.  Replimune Group

 Performance 
       Timeline  
Gracell Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gracell Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Gracell Biotechnologies is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
Replimune Group 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Replimune Group are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Replimune disclosed solid returns over the last few months and may actually be approaching a breakup point.

Gracell Biotechnologies and Replimune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gracell Biotechnologies and Replimune

The main advantage of trading using opposite Gracell Biotechnologies and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gracell Biotechnologies position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.
The idea behind Gracell Biotechnologies and Replimune Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stocks Directory
Find actively traded stocks across global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal